User menu

Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

Bibliographic reference Turine, G. ; Peeters, A. ; Hermans, C. ; Eeckhoudt, S. ; Duprez, Thierry. Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer. In: Acta Neurologica Belgica, (2017)
Permanent URL http://hdl.handle.net/2078.1/184652
  1. Heidbuchel Hein, Verhamme Peter, Alings Marco, Antz Matthias, Diener Hans-Christoph, Hacke Werner, Oldgren Jonas, Sinnaeve Peter, Camm A. John, Kirchhof Paulus, Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation, 10.1093/europace/euv309
  2. Diener HC, Bernstein R, Butcher K, Campbell B, Cloud G, Davalos A, Davis S, Ferro JM, Grond M, Krieger D, Ntaios G, Slowik A, Touzé E, Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion, 10.1177/1747493016669849
  3. Kafke Waldemar, Kraft Peter, Department of Neurology, Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report, 10.1159/000447531
  4. Gawehn Annemarie, Ayari Yassine, Heuschkel Christian, Kaste Matthias, Kermer Pawel, Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report, 10.1186/s13256-016-1050-0
  5. Berrouschot Jörg, Stoll Anett, Hogh Theresa, Eschenfelder Christoph Cyrill, Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab: Table., 10.1161/strokeaha.116.013550